Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 99: 1719-1727, 2005. First published June 23, 2005; doi:10.1152/japplphysiol.01419.2004
8750-7587/05 $8.00
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
99/5/1719    most recent
01419.2004v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morris, C. A.
Right arrow Articles by Sweeney, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morris, C. A.
Right arrow Articles by Sweeney, H. L.

Attenuation of skeletal muscle atrophy via protease inhibition

Carl A. Morris,1 Linda D. Morris,1 Ann R. Kennedy,2 and H. Lee Sweeney1

1Department of Physiology and the Pennsylvania Muscle Institute and 2Department of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania

Submitted 27 December 2004 ; accepted in final form 20 June 2005

Skeletal muscle atrophy in response to a number of muscle wasting conditions, including disuse, involves the induction of increased protein breakdown, decreased protein synthesis, and likely a variable component of apoptosis. The increased activation of specific proteases in the atrophy process presents a number of potential therapeutic targets to reduce muscle atrophy via protease inhibition. In this study, mice were provided with food supplemented with the Bowman-Birk inhibitor (BBI), a serine protease inhibitor known to reduce the proteolytic activity of a number of proteases, such as chymotrypsin, trypsin, elastase, cathepsin G, and chymase. Mice fed the BBI diet were suspended for 3–14 days, and the muscle mass and function were then compared with those of the suspended mice on a normal diet. The results indicate that dietary supplementation with BBI significantly attenuates the normal loss of muscle mass and strength following unloading. Furthermore, the data reveal the existence of yet uncharacterized serine proteases that are important contributors to the evolution of disuse atrophy, since BBI inhibited serine protease activity that was elevated following hindlimb unloading and also slowed the loss of muscle fiber size. These results demonstrate that targeted reduction of protein degradation can limit the severity of muscle mass loss following hindlimb unloading. Thus BBI is a candidate therapeutic agent to minimize skeletal muscle atrophy and loss of strength associated with disuse, cachexia, sepsis, weightlessness, or the combination of age and inactivity.

hindlimb unloading; protease inhibitors; Bowman-Birk inhibitor; protein degradation



Address for reprint requests and other correspondence: H. L. Sweeney, Dept. of Physiology and the Pennsylvania Muscle Institute, Univ. of Pennsylvania School of Medicine, A-700 Richards Bldg., 3700 Hamilton Walk, Philadelphia, PA 19104–6085 (e-mail: lsweeney{at}mail.med.upenn.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
M. Vermaelen, P. Sirvent, F. Raynaud, C. Astier, J. Mercier, A. Lacampagne, and O. Cazorla
Differential localization of autolyzed calpains 1 and 2 in slow and fast skeletal muscles in the early phase of atrophy
Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1723 - C1731.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. Arbogast, J. Smith, Y. Matuszczak, B. J. Hardin, J. S. Moylan, J. D. Smith, J. Ware, A. R. Kennedy, and M. B. Reid
Bowman-Birk inhibitor concentrate prevents atrophy, weakness, and oxidative stress in soleus muscle of hindlimb-unloaded mice
J Appl Physiol, March 1, 2007; 102(3): 956 - 964.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. Koncarevic, R. W. Jackman, and S. C. Kandarian
The ubiquitin-protein ligase Nedd4 targets Notch1 in skeletal muscle and distinguishes the subset of atrophies caused by reduced muscle tension
FASEB J, February 1, 2007; 21(2): 427 - 437.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. R. Judge, A. Koncarevic, R. B. Hunter, H.-C. Liou, R. W. Jackman, and S. C. Kandarian
Role for I{kappa}B{alpha}, but not c-Rel, in skeletal muscle atrophy
Am J Physiol Cell Physiol, January 1, 2007; 292(1): C372 - C382.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
E. E. Dupont-Versteegden, J. D. Fluckey, M. Knox, D. Gaddy, and C. A. Peterson
Effect of flywheel-based resistance exercise on processes contributing to muscle atrophy during unloading in adult rats
J Appl Physiol, July 1, 2006; 101(1): 202 - 212.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.